Home›Stock Screener›Roselabs Finance›Intrinsic Value

Roselabs Finance Intrinsic Value

Roselabs Finance intrinsic value. Roselabs Finance (ROSELABS) median intrinsic value is ₹6.30 from 1 valuation models (range ₹6–₹6), vs current price ₹21.00 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse ROSELABS income statement for revenue, profit, balance sheet and cash flow data.

Market Price (CMP)
₹21.00
Primary Intrinsic Value
₹6.30
Market Cap
₹21.0 Cr
-70.0% Downside
Median Value
₹6.30
Value Range
₹6 - ₹6
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

ROSELABS Valuation Methods Summary — DCF, Graham Number & P/E

Roselabs Finance intrinsic value across 1 models vs current price ₹21.00 — upside/downside and value range per method. Analyse ROSELABS FII DII holdings to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
Revenue Multiple Method revenue ₹6.30 ₹5.67 - ₹6.93 -70.0% Revenue/Share: ₹1.00, P/S: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

ROSELABS Intrinsic Value vs Market Price — All Valuation Models

Roselabs Finance fair value range ₹6–₹6 vs current market price ₹21.00 across 1 valuation models. For current market price and key ratios, visit ROSELABS share price.

ROSELABS Intrinsic Value Analysis — Undervalued or Overvalued?

Roselabs Finance median intrinsic value ₹6.30, current price ₹21.00 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of ROSELABS?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Roselabs Finance (ROSELABS) is ₹6.30 (median value). With the current market price of ₹21.00, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹6.30 to ₹6.30, indicating ₹6.30 - ₹6.30.

Is ROSELABS undervalued or overvalued?

Based on our multi-method analysis, Roselabs Finance (ROSELABS) appears to be trading above calculated value by approximately 70.0%.

ROSELABS Financial Health — Key Ratios vs Industry Benchmarks

Roselabs Finance financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Operating Margin -1.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level

ROSELABS Cash Flow Quality — Operating & Free Cash Flow

Roselabs Finance operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10